Page last updated: 2024-09-04

levofloxacin and Sclerosis, Systemic

levofloxacin has been researched along with Sclerosis, Systemic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Horino, T; Ichii, O; Inotani, S; Matsumoto, T; Terada, Y1
Cervera, R; de La Red, G; Font, J; Lladó, A; Mejía, JC; Mensa, J1

Other Studies

2 other study(ies) available for levofloxacin and Sclerosis, Systemic

ArticleYear
Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome (DRESS/DIHS) caused by levofloxacin in a patient with systemic scleroderma, rheumatoid arthritis, and Sjogren syndrome.
    Contact dermatitis, 2019, Volume: 80, Issue:4

    Topics: Aged; Anti-Bacterial Agents; Arthritis, Rheumatoid; Dermatitis, Exfoliative; Drug Hypersensitivity Syndrome; Female; Follow-Up Studies; Herpesvirus 6, Human; Humans; Levofloxacin; Lymphadenopathy; Patch Tests; Rare Diseases; Scleroderma, Systemic; Sjogren's Syndrome; Tomography Scanners, X-Ray Computed; Treatment Outcome

2019
Bilateral Achilles tendinitis with spontaneous rupture induced by levofloxacin in a patient with systemic sclerosis.
    Clinical rheumatology, 2003, Volume: 22, Issue:4-5

    Topics: Achilles Tendon; Cyclophosphamide; Drug Therapy, Combination; Follow-Up Studies; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prednisone; Risk Assessment; Rupture, Spontaneous; Scleroderma, Systemic; Severity of Illness Index; Tendinopathy

2003